– Kingswood Capital Management, LP (“Kingswood”) announced that Bonaccord Capital Partners (“Bonaccord”) has made a passive minority investment in the firm.
– Bonaccord is a private equity firm providing growth capital and strategic support to middle-market private markets sponsors.
– The investment will expand Kingswood’s capital base and allow reinvestment into the firm, supporting future growth.
– There will be no changes to Kingswood’s management, investment strategy, or operations.
– Kingswood, based in Los Angeles, focuses on buyouts of middle-market businesses with operational improvement potential.
– The firm has maintained strong performance despite broader market turbulence and reduced deal flow.
– Since 2021, Kingswood has completed three institutional fundraises.
– Fund III closed in summer 2024 in just 90 days with $1.5 billion in commitments, surpassing the $1.0 billion target.
– Recent acquisitions include Kodak Alaris and The Vitamin Shoppe.
– On November 3, Kingswood closed its largest transaction to date: the acquisition of Drive DeVilBiss Healthcare.
– Alex Wolf, Founder and Managing Partner of Kingswood, stated that Bonaccord’s investment is a major milestone and a strong vote of confidence in Kingswood’s approach and vision.
– Ajay Chitkara, Managing Partner at Bonaccord, expressed enthusiasm about partnering with Kingswood and praised its investment track record, LP engagement, and growth in a competitive market.
